Date: August 28, 2019
Time: 01:00PM - 02:00PMYou must be registered to participate!
Individuals may experience high stomal output for several reasons. This may result in readmission with dehydration and/or kidney injury. Preventing readmission and preserving kidney function in these patients requires accurate I and O recording –of stool and urine. The purpose of this webinar is to provide the clinician with tools to develop plans for pharmacological management to support nutrition and hydration management (discussed in the August 14 Webinar) to aid with output management to prevent dehydration, to prevent kidney injury, and to improve the quality of life for these patients.
Upon successful completion of this educational program, the learner should be able to:
This webinar is supported by B. Braun Medical. The WOCN® Society does not endorse specific products and services.
Nurses – ANCC and CBRN Accreditation Statements
The Wound, Ostomy and Continence Nurses Society is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
The Wound, Ostomy and Continence Nurses Society is approved by the California Board of Registered Nursing, Provider Number CEP 15115.
Contact Hour(s): 1.00, which includes 1.00 hour(s) of pharmacology credit
DISCLAIMER: Accreditation refers to educational content only and does not imply ANCC, CBRN or WOCN Society endorsement of any commercial product or service.
Target Audience: RN, Nurse Practitioners, Health Care Professionals who work with WOC patients.
To Receive Credit:
The planners and faculty for this program have nothing to disclose unless listed below. All potential Conflicts of Interest have been reviewed by the Lead Nurse Planner, Nurse Planner, and Director of Education, and resolved according to the WOCN Society policy to ensure that no bias exists as a result of disclosed relevant financial relationships with Commercial Interest Organizations.
· Mary Arnold Long, DNP, APRN, CRRN, CWOCN-AP, ACNS-BC: Molnlycke – Consultant/Speakers bureau
· Matt Widanski, PharmD: Nothing to disclose